CAS 151213-15-9

1-Cyclopropyl-6,8-difluor-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-chinolinecarbonsäure

Beschreibung:

1-Cyclopropyl-6,8-difluor-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-chinolinecarbonsäure, mit der CAS-Nummer 151213-15-9, ist eine synthetische organische Verbindung, die durch ihre komplexe bicyclische Struktur gekennzeichnet ist, die einen Chinolinkern und ein Pyrrolopyridin-Moiety umfasst. Diese Verbindung weist mehrere funktionelle Gruppen auf, darunter eine Carbonsäure und Fluorsubstituenten, die ihre chemische Reaktivität und biologische Aktivität beeinflussen können. Die Anwesenheit der Cyclopropylgruppe kann zu ihren einzigartigen sterischen und elektronischen Eigenschaften beitragen. Ihre strukturelle Komplexität deutet auf potenzielle Anwendungen in der medizinischen Chemie hin, insbesondere bei der Entwicklung von Arzneimitteln, die auf spezifische biologische Wege abzielen. Die Difluorierung kann die Lipophilie und die metabolische Stabilität erhöhen, während die gesamte molekulare Architektur so gestaltet werden könnte, dass sie mit spezifischen Rezeptoren oder Enzymen interagiert. Wie bei vielen Verbindungen dieser Art wäre es entscheidend, ihre Löslichkeit, Stabilität und Wechselwirkung mit biologischen Systemen zu verstehen, um ihre potenziellen therapeutischen Anwendungen zu bewerten.

Formel: C₂₀H₂₁F₂N₃O₃

InChl: InChI=1/C20H21F2N3O3/c21-14-6-12-17(25(11-3-4-11)8-13(19(12)26)20(27)28)16(22)18(14)24-7-10-2-1-5-23-15(10)9-24/h6,8,10-11,15,23H,1-5,7,9H2,(H,27,28)/t10-,15+/m0/s1

InChI Key: InChIKey=WEXQOLCYKFJAJZ-ZUZCIYMTSA-N

SMILES: FC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N3C[C@]4([C@@](C3)(NCCC4)[H])[H])C5CC5

Synonyme:

• 1-Cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid
• 3-quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-
• 6H-Pyrrolo[3,4-b]pyridine, 3-quinolinecarboxylic acid deriv.
• 3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)-
• Moxifloxacin Imp. A RS IP
• Moxifloxacin hydrochloride impurity A
• Moxifloxacin Related CoMpound A
• Moxifloxacin impurity 1/Moxifloxacin EP Impurity A/Moxifloxacin Difluoro Analog/8-Desmethoxy-8-Fluoro Moxifloxacin/1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• Moxifloxacin Related Matter 1
• Moxifloxacin impurity A
• 1-cyclopropyl-6-fluoro-7-amino-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-7-amino-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 7-amino-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxoquinoline-3-carboxylic acid
• 3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)- USP/EP/BP
• Moxifloxacin EP Impurity A : Moxifloxacin Impurity A
• 1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
• Moxifloxacin EP IMpurity A
• Moxifloxacin Related Compound A (25 mg) (1-cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
• 8-Desmethoxy-8-fluoro Moxifloxacin
• 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo-[3,4-b]pyridin-6(2H)-yl)-4-oxo-1
• Moxifloxacin Hydrochloride IMpurity-A(EP)(USPRC A)
• Moxifloxacin IMp. A (EP,BP)
• 8-Ddesmethoxy-8-fluoroMoxifloxacin
• 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• Moxifloxacin EP Impurity A HCl USP/EP/BP
• Moxifloxacin EP Impurity A/ Moxifloxacin Related Compound A (Moxifloxacin Difluoro Analog)
• 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo-[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-d
• Moxifloxacin Related Compound A (25 mg) (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
• Moxifloxacin related substance A
• USP Moxifloxacin Related Compound A
• Moxifloxacin impurity 2/Moxifloxacin EP Impurity A HCl/Moxifloxacin Difluoro Analog HCl/8-Desmethoxy-8-fluoro Moxifloxacin HCl/1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid Hydrochloride
• Moxifloxacin Related Matter A
• Mosisasin ImpurityA

Moxifloxacin Related Compound A (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)

CAS: 151213-15-9

Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticides

Formel: C₂₀H₂₁F₂N₃O₃

Farbe und Form: White Off-White Powder

Molekulargewicht: 389.1551

Ref: 45-1448617

3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-

CAS: 151213-15-9

Formel: C₂₀H₂₁F₂N₃O₃

Reinheit: 95%

Farbe und Form: Solid

Molekulargewicht: 389.3958

Ref: IN-DA001N5P

Moxifloxacin EP Impurity A HCl (Moxifloxacin USP Related Compound A HCl)

CAS: 151213-15-9

Formel: C₂₀H₂₁F₂N₃O₃·HCl

Farbe und Form: Pale Yellow Solid

Molekulargewicht: 389.40 36.46

Ref: 4Z-M-2714

1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

CAS: 151213-15-9

1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Reinheit: 95%

Molekulargewicht: 389.4g/mol

Ref: 54-PC1007442

1-Cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid

CAS: 151213-15-9

Farbe und Form: Neat

Ref: 86-MM0885.04

Moxifloxacin EP Impurity A

CAS: 151213-15-9

Formel: C₂₀H₂₁F₂N₃O₃

Molekulargewicht: 389.40

Ref: ST-EA-CP-M26001

8-Desmethoxy-8-fluoro Moxifloxacin

CAS: 151213-15-9

Impurity Moxifloaxacin EP Impurity A
Stability Hygroscopic
Applications 8-Desmethoxy-8-fluoro Moxifloxacin (Moxifloaxacin EP Impurity A) is an impurity of Moxifloxacin (M745000).
References Martel, A., et al.: Drugs Fut., 22, 109 (1997), Tobin, C., et al.: J. Antimicrob. Chemother., 42, 278 (1998),

Formel: C₂₀H₂₁F₂N₃O₃

Farbe und Form: Neat

Molekulargewicht: 389.4

Ref: TR-D445850

1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

CAS: 151213-15-9

Formel: C₂₀H₂₁F₂N₃O₃

Reinheit: 95%

Molekulargewicht: 389.403

Ref: 10-F230378

8-Desmethoxy-8-fluoro moxifloxacin

CAS: 151213-15-9

8-Desmethoxy-8-fluoro moxifloxacin is a photolytic drug that is used to treat bacterial infections. It has a high degree of antibacterial activity against methicillin-resistant staphylococcus aureus, including methicillin resistant strains of Staphylococcus epidermidis. 8-Desmethoxy-8-fluoro moxifloxacin hydrochloride is produced by the addition of hydrochloric acid to moxifloxacin, which is then purified by ion chromatography. The compound has been shown to have good stability in human plasma and urine. It also shows excellent recoveries in acetonitrile and quantification results in flow rates.

Formel: C₂₀H₂₁F₂N₃O₃

Reinheit: Min. 95%

Molekulargewicht: 389.4 g/mol

Ref: 3D-FD21225